分析阿斯特拉加林的治疗潜力:洞察目标相互作用和机制
1Department of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
Xenobiotica; the fate of foreign compounds in biological systems
|September 11, 2025
概括
阿斯特拉加林 (AST) 是一种黄类药物,显示出治疗神经退行性疾病和抑郁症的潜力. 需要进一步的研究来验证其有效性并了解其神经保护机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 一种黄类药物阿斯特拉加林 (AST) 正在研究其对神经退行性疾病 (如帕金森病 (PD),认知障碍 (CI) 和抑郁症) 的潜在治疗作用.
- 在治疗这些疾病方面,AST的有效性及其类似药物的特性背后的精确机制在很大程度上仍未被阐明.
研究的目的:
- 综合评估阿斯塔加林的代谢物概况,药理动力学,毒性,分子标和潜在的生物活性.
- 通过检查其与关键生物通路和点的相互作用,探索AST作为神经治疗剂的潜力.
主要方法:
- 通过计算分析,确定了AST的31种II期代谢物 (O-糖化,O-硫化,甲基化).
- 利宾斯基的五项规则被应用来评估AST及其代谢物的药物相似性.
- 分析了AST与神经炎症标 (例如IL1B,IL6,TNF,SERT) 的结合 afinities,以及它与神经炎症通路的关联.
主要成果:
- 确定了AST的31种II期代谢物,其中一些代谢物部分违反了Lipinski关于分子量和键捐赠者的五项规则.
- AST及其代谢物显示出良好的安全性和潜在的抗神经退行和抗抑郁作用.
- AST对关键的神经炎症标,包括IL1B,IL6,TNF,NOS2,PTGS2,SERT,caspase-3,caspase-8和GABAa受体表现出强烈的结合亲缘关系,这表明它在神经炎症途径中发挥了作用.
结论:
- 阿斯特拉加林在神经退行性疾病和抑郁症中具有有利的安全性和潜在的治疗作用.
- AST与多个神经炎症点的相互作用表明了神经保护的有希望的机制.
- 这些发现为进一步的体外和体内研究提供了基础,以验证AST作为神经治疗候选药物的有效性.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:24Principles of Drug Action
8.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.2K
01:14Agonism and Antagonism: Quantification
990
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
990
01:26Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
01:25Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
01:29Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K